When the body's cells become abnormal and duplicate out of control a tumour is formed, these may be cancerous (spreading) or benign (non-cancerous). Normal body cells divide in a controlled and relativly slow rate, in malignant cells the duplication is uncontrolled and often at a very rapid rate. If the tumour (also refered to as a growth or neoplasm) is malignant (spreading) the disease may develop in other parts of the body where secondary tumours may form (known as metastasis).Cancer is not a single disease but a wide range of different diseases of which there well over a hundred types. Cancers can be classified into two broad types: haematological (malignancies of the blood) or solid tumours. The name of the cancer depends on the type of tissue and/or site it develops in. For example a sarcoma is a cancer arising from bone, muscle or connective tissue. Carcinoma is cancer arising from epithelial tissue (cells of the glands and the outer layer of skin that lines blood vessels, hollow organs and the body's orifices).
What causes cancer ? The cause of most cancers remains unknown. A minority of cancers are known to be hereditary (inherited). For example some breast cancers, retinoblastomas, and Wilms' tumours are thought to be hereditary. In rare cases the family may have a history of cancers (Li-Fraumeni Syndrome) [1]. However most cancers have no obvious hereditary cause. Carcinogens are chemicals or enviromnental factors that may cause normal cells to become abnormal and cancerous by damage or mutate a cells genetic material (DNA and RNA). For example smoking is known to increase a persons risk of lung cancer, likewise over-exposure to ultraviolet sun light increases the risk of melanoma, and inhilation of asbestos dust can cause mesophelioma (cancer of the lining of the lungs). Some viruses are known to be carcinogens, for example the HTLV-1 virus is associated with leukaemia. Radiation exposure has also been linked with cancer incidence. Other factors such as diet and excercise may influence cancer incidence.
One or more 'insults' (exposure to carcinogens) may result in damage or modifications to a cells DNA. Oncogenes are genes present in the DNA of every cell and carry out normal functions but have the potential to make a normal cell turn cancerous. These genes help regulate normal growth and development, but an abnormal change may cause them to produce irregular or excessive amounts of chemical signals. These may stimulate extreme or abnormal cell growth. On the other hand some genes are thought to be protective against cancer and viruses causing badly damaged cells to self-destruct (apoptosis). If these such genes are damaged or absent then the risk of cancer may increase. For example deletion of the P53 gene has been identified in a range of cancers.
Childhood cancer is rare, about 1 in every 600 children aged under 15 develop cancer, still very little is known about it's causes [2]. Childhood cancers represent around 1% of all cancers, though in terms of life years that may be saved by curing children with cancer this proportion is much higher. Compared with adult cancers they tend to have different histologies and occur in different sites of the body [3]. Common adult cancers such as lung, breast, colon, and stomach are extremely rare among children. On the other hand some types of cancer are almost exclusively found in children, especially embryonal tumours which arise from cells associated with the foetus, embryo, and early postnatal period. Treating children requires different considerations compared with adult oncology, for example potential treatment side effects may be different to those in adults. Because of these differences between childhood and adult cancers most children are treated in specialist paediatric oncology units, in the UK about 80% of children are treated at a UKCCSG centre. The overall cure rate for childhood cancer has drastically improved over the last 2 decades in association with clinical trials and the development of new treatments [4,5].
Leukaemia is the most common type of childhood cancer, representing about one third of all cancers in under 15 year olds. Leukaemia is a condition where too may underdeveloped white blood cells are found in the blood and bone marrow. Four fifths of childhood leukaemia's are acute lymphatic leukaemias (ALL), other types include acute myeloid leukaemia (AML) and chronic myeloid leukaemia (CML). Brain tumours are the most common solid tumours in childhood, and make up about a fifth of all children's cancers. There are many different types of brain tumours; medulloblastoma, astrocytoma and brainstem glioma are the most common.
Neuroblastoma (sympathetic nervous system), retinoblastoma (eye), Wilms' tumour (kidneys), and hepatobalstoma (liver) are most usually found in infants or young children. Other malignancies found in children and young adults include Lymphomas (Hodgkin's and Non-Hodgkins lymphoma), soft tissue sarcomas (including rhabdomyosarcoma), bone cancer (osteosarcoma and Ewing's sarcoma), plus a number of less common childhood cancers. Histiocytocis is rare; it is not a true cancer, but in many respects behaves like one.
About one in three people will have cancer during their lifetime, and after heart disease cancer is now the most common cause of death in western countries. [7] Adult cancer is a diverse range of different diseases. The chart below shows the distribution of different cancer sites for Kentucky (USA) in 1993 based on data provided by the Kentucky Cancer Registry[8].
The incidence and types of cancer varies between and also within different countries. It will depend on demographic (population), environmental and other factors. For example there are differences in cancer incidence between different racial groups, diet and climate may also influence cancer incidence [9]. In particular the age distribution of the population will influence the incidence of different types of cancer. The peak incidence of many adult cancers is after the age of 45 (eg. lung, breast and prostate cancer). Other cancers such as bone tumours, Hodgkin's disease, and cervical cancer are more common in younger adults. Leukaemia is found in people of all ages and is one of the most common type of cancers in adults aged under 35. Age specific cancer incidence rates are shown below (for all types of cancer combined).
This guide aims to introduce the main types of cancer in the context of the body system to which they most closely identify. For example in the respiratory system (breathing) lung cancer is a common neoplasm. Overall this is one of the most common types of cancer and smoking is known to increase a persons risk for this disease. In the digestive system colorectal cancer (colon / rectum) is another common tumour. Other cancers of the digestive system include those of the pancreas, stomach, esophagus, and other organs. For the cardiovascular system (heart and blood) cancers include leukaemia and plasma cell tumours. In the lymphatic system tumours are classified as either Hodgkin's or non-Hodgkin's Lymphoma. Thyroid cancer is the most common type of tumour in the endocrine system (hormones), while brain and spinal tumours are found in the central nervous system.
Breast cancer is one of the most common neoplasms, predominantly found in women (less than 1% are in males). Associated with the female reproductive system are cervical, ovarian, and other genealogical cancers. In males prostate cancer is one of the major neoplasms, other cancers of the male reproductive system iclude testis and penile cancer. Associated with the urinary system are bladder and kidney cancers. Sarcomas (bone, soft tissue, or connective tissue tumours) are related to the musculoskeletal system. Skin cancers include melanoma and basal cell carcinoma. Head and neck cancers include those of the oral and nasal cavities.
The cancers mentioned above are some of the more common types, they are introduced in more detail throughout this guide together with other less frequent types.
This is the removal of a small section of the tumour, the sample will be analysed by a histopathologist in order to establish a precise diagnosis. Surgical procedure. This may be a needle biopsy, where a very fine needle is used to take a tiny sample of the tumour. Occasionally a surgeon may remove the whole tumour prior to diagnosis; a resection biopsy.
is the branch of medicine that specialises in the study and treatment of blood and blood tissues (including bone marrow). A blood count is where the various types cells in the blood are measured. This may aid diagnosis and will be used during treatment to monitor toxicity. The Haematologist may also examine samples from a bone marrow aspiration (needle into the bone) and samples of spinal fluid from a lumbar puncture (needle between the vertebra of the spine).
the study of cells relating to the disease. (Histology is the microscopic study of cells and tissues, Pathology is the study of the disease). The histopathologist will determine a precise diagnosis by laboratory tests and microscopic examination of the cells.
is where normal cells go through physical changes in order to form the different specialised tissues of the body. Malignant cells may range from well-differentiated (closely resembling the tissue of origin) or undifferentiated or anaplastic (bearing little similarity to the tissue of origin). In general it is the undifferentiated or anaplastic histologies which are more aggressive.
A substance in the body that may indicate the presence of cancer. Markers may be secreted by the tumour itself or produced by the body in response to the cancer. Tumour markers may aid diagnosis or give an indicator of how treatment is progressing. These markers are usually specific to certain types of cancer. For example neuron-specific enolase (NSE) is associated with a number of types of cancers, in particular neuroblastoma. Also alphafetoprotein (AFP) levels are often abnormally high in patients with Germ cell tumours.
Medical Imaging types of medical imaging include:
Not spreading, usually a more mild disease.
Cancerous, where the tumour grows uncontrollably and may spread.
A tumour restricted to a single site.
Where the tumour has spread to other parts of the body beyond the primary site. Metastatic sites (secondaries) my be regional or distant from the original tumour.
Staging is where the disease is categorised as to how far it has spread. The precise staging system used will depend on the type of cancer the patient has. In general low stage patients are those with localised tumours that are easily resectable, whilst high stage patients are those with widespread metastases. The treatment given may largely depend upon which stage the patient is at diagnosis.
is the expected outcome of a disease and it's treatment, this may be influenced by a variety of factors such as stage, age, site etc. depending on the particular type of cancer. For example, in general a patient with localised disease may have a more favourable prognosis compared to a patient with widespread disease which may be less favourable.
is where the symptoms of cancer are no longer present. There is no longer any evidence of the disease using the available investigations.
This is when the disease reoccurs after a period in remission.
This is where the cancer is resistant to treatment, patient may nevergo into remission, possibly with stable or progressive disease.
This is where the patient is staged again after a period of treatment to access the response to therapy.
When treatment is complete the periodic visits to the physician are needed to monitor the patient and ensure there has been no recurrence of the disease.
Curative treatment - treatment to destroy the cancer.
Palliative treatment treatment which relieves the symptoms and pain.
Since the 1960's the development and use of drugs has dramatically improved the prognosis for many types of cancer. Chemo- means chemicals, for most types of cancer chemotherapy will consist of a number of different drugs, this is known as combination chemotherapy. Chemotherapy may be given in a variety of ways; Intravenously (IV) -into a vein is the most common, Intramuscularly (IM) -injection into a muscle, Orally -by mouth, Subcutaneously (SC) -injection under the skin, Intralesionally (IL) -directly into a cancerous area, Intrathecally (IT)-into the fluid around the spine, Topically -medication will be applied onto the skin.
Bone Marrow Transplantation (BMT)
The bone marrow is destroyed by high dose chemotherapy and possibly radiotherapy which has been given to kill malignant cells in the body. Healthy matching marrow is then transplanted into the patient.
New approaches - Gene therapy / Immunotherapy
In the future patients might be immunised against their own cancers by injecting them with their own tumour cells after they have been genetically modified. The gene-modified tumour cells may encourage the patients own immune system to destroy the cancer cells. Tumour necrosis factor (TNF) and interleukin-2 (IL-2) are substances associated with the immune system which encourage anititumour activity.
Acute Transient. Some side effects may be of short duration. May be sudden or severe.
Chronic Long lasting. Some side effects may be
long lasting e.g. kidney damage.
Immuno-suppressive - Drugs may dampen the immune system making the patient prone
to infections.
Neutropenia reduced levels of white cells in the blood. Febrile neutropenia -with fever.
WHO toxicity gradings World Health Organisation toxicity grading guidelines. In general these range from grade 0 (none) to grade 4 (life threatening).
Late effects It is possible that treatment may have delayed effects e.g. on fertility and growth.
two general approaches include a) the mass screening of thousands of natural substances to see if they have any anti cancer potential; or b) making new compounds in the laboratory e.g. creating analogues of existing drugs (slightly modified chemical structures) designed to make the drug more potent.
Pre-clinical testing of drugs.
New drugs may be tested on animals to indicate the maximum doses, toxicities and anti cancer potential before they are tested on humans (see phase I trials).
experiments may be in vitro (in the test tube) or in vivo (in the body). Much laboratory work uses cell cultures (cells grown in the lab); either from established cell lines or from material collected at biopsy/surgery.
There is a great deal of research investigating the mechanisms of how drugs are metabolised and absorbed by the body's cells. Growing knowledge in this field provides the foundations for improving the anticancer potential for existing drugs and for developing new 'designer' drugs. Other work includes research into the machanisms of drug resistance.
cytogenetics. During recent years there has been rapid advances in the understanding of tumour biology at the genetic level. Research into the genes associated with different cancers include the identification of oncogenes, tumour supressor genes. This is a key area of cancer research, providing a basis for the development of new treatments and new diagnostic tools. In the future treatment may be more tailored to the biological features of the cancer rather than the standard clinical features.
Some Studies are experimental which make in intervention e.g. clinica l trials, others are observational in which no medical intervention is made. Studies may also be prospective ie. ongoing into the future, or retrospective ie. looking at historical data. In general studies aim to test a hypothesis (theory) by disproving null hypothesis (the opposite theory) e.g. in a trial of a new drug the null hypothesis might be that the new drug has no effect on survival.
Tests new types of treatment and aim to define a safe dose that will be used for further studies. This is usually the first testing of a treatment on humans after extensive laboratory work. Recruitment for Phase I trials are usually from patients for whom no other effective therapy is known.
Test the anti cancer effects of the new treatment, and include very detailed toxicity investigations. If there is effective antitumour activity, it may be incorporated in a future phase III study.
Compare one or more treatments of proven efficacy. Often patients will be randomised between an established 'standard' treatment and a new 'experimental' treatment - it is not known which is the better treatment.
Randomisation Treatment is randomly allocated to ensure there is no systematic bias in the results.
Ethical approval all new trials have to first be approved by an independent ethics committee.
Informed consent is where patients agree to a treatment / randomisation having a reasonable understanding of it.
Morbidity Looking at the incidence or prevalence of a disease in a population.
Mortality Looking at the death rates caused by a disease.
The study of populations. Regional and National cancer registries record all cancers enabling population based studies in cancer to be carried out. Knowing how many people get a type of cancer out of the overall population provides the information needed to calculate incidence rates.
Longitudanal Studies are studies where individuals are followed over time. A fixed population (cohort) may be monitored over a number of years.
Cross-sectional Studies are studies that are carried out at just one point in time.
Case Control Studies are where cases are compared to controls, in order to avoid bias the controls are matched for factors such as age and sex. The aim is to investigate possible associations between certain factors and risk of disease. For example a study investigating smoking and the risk of lung cancer.
Meta Analysis is where data from a number of studies are lumped together in order to provide evidence for or against a hypothesis.
Inside the cell's nucleus, DNA is tightly twisted and packed into 23 pairs of chromosomes (one chromosome in each pair comes from each parent).
There are 46 human chromosomes which are estimated to contain about 100,000 individual genes that determine each person's inherited human characteristics. Each gene is a segment of double-stranded DNA which holds the information for making a specific molecule, usually a protein. This information (or code) lies in varying sequences of vast numbers of pairs of the four chemical bases that make up the DNA. A change in the sequence (a mutation), or missing sequences (deletion) of these bases may result in an altered protein that does not work properly, or a failure to produce that protein altogether.
component | meaning | example |
CUT- | skin | subcutaneous layer = layer below the skin |
DERMA- | skin | dermatology = study of the skin and its diseases |
EPI- | upon | epidermis = layer above the dermis |
LIPO- | fat | lipoatrophy = atrophy of fat below the skin |
MELAN- | black | melanin = the black pigment in the skin |
ONYCH- | nail | onychectomy = excision of a nail |
PACHY- | thick | pachyderma = abnormal thickening of skin |
SCLERO- | hand / tough | scleroderma = chronic hardening of the skin |
SUDOR- | sweat | sudorific = an agent that promotes sweat |
-ITIS | inflammation | dermatitis = inflammation of the skin |
-OMA | tumour | melanoma = black coloured skin tumour |
-OSIS | condition / disease | dermatophytosis = a fungal infection of the skin |
Internet Resources for Basal Cell
Carcinoma
Internet Resources for Squamous Cell
Carcinoma (skin)
Related Abbreviations and Acronyms:
BCC | Basal Cell Carcinoma |
BMR | Basal Metabolic Rate |
LMM | Lentigo Maligna Melanoma |
MM | Malignant Melanoma |
NBCCS | Nevoid basal cell carcinoma syndrome |
NM | Nodular Melanoma |
NMSC | Non Melanoma Skin Cancer |
SC | Subcutaneous |
SCC | Squamous Cell Carcinoma |
SSM | Superficial Spreading Melanoma |
UVR | Ultra Violet Radiation |
component | meaning | example |
ARTHR- | joint | arthritis = inflammation of the bone |
CHONDR- | cartilage | chondrocyte = a cartilage cell. |
COST- | rib | costalgia = pain in the ribs. |
OSTEO- | bone | osteosarcoma = a type of bone tumour |
SCOLIO- | curved / crooked | scoliosis = curvature of the spine. |
-LYSIS | disintegration | osteomyelitis = inflammation of the bone |
-OSIS | disease | osteoporosis = reduced bone mass-fracture prone |
-TOMY | incision into | thoracotomy = incision into chest/thorax |
Related Abbreviations and Acronyms:
C1 - C7 | Cervical vertebrae (spine eg. C7 = seventh cervical vertebra) |
EICESS | European Intergroup Ewing's Sarcoma Study |
EOI | European Osteosarcoma Intergroup |
GCT | Giant Cell Tumour Context: bone tumours |
IESS | Intergroup Ewing's Sarcoma Study (USA) |
L1 - L5 | Lumbar vertebrae 1 - 5 (spine eg. L1 = 1st lumbar vertebra) |
OS | Osteogenic sarcoma (context bone tumours) |
PNET | Peripheral neuroectodermal tumour Context: Bone tumours - see Ewing's tu |
T1 - T12 | Thoracic vertebrae 1-12 (spine eg. T10 = tenth thoracic vertibra) |
component | meaning | example |
SARC- | tissue | sarcoma = tumour of supportive tissues (muscle, bone etc.) |
INTRA- | into | intramuscular injection = injection into a muscle |
MYO- | muscle | myocardium = heart muscle |
BI- | two | biceps = muscles with two heads |
TRI- | three | triceps = muscles with three heads |
Related Abbreviations and Acronyms:
ARMS | Alveolar rhabdomyosarcoma |
IM | Intramuscular - into a muscle |
MPNST | Malignant Peripheral Nerve Sheath Tumour |
NRSTS | Non-Rhabdomyosarcoma Soft Tissue Sarcoma |
RMS | Rhabdomyosarcoma |
component | meaning | example |
CARDIO- | heart | echocardiogram = sound wave image of the heart. |
CYTE- | cell | thrombocyte = clot forming cell. |
HAEM- | blood | haematoma - a tumour or swelling filled with blood. |
THROMB- | clot, lump | thrombocytopenia = deficiency of thrombocytes in the blood |
ETHRO- | red | ehtrocyte = red blood cell |
LEUKO- | white | leukocyte = white blood cell |
SEP, SEPTIV- | toxicity due to micro-organisms | septicaemia |
VAS- | vessel / duct | cerebrovascular = blood vessels of the cerebrum of the brain. |
HYPER- | excessive | hyperglycaemia = excessive levels of glucose in blood. |
HYPO- | deficient / below | hypoglycaemia = abnormally low glucose blood levels. |
-PENIA | deficiency | neutropenia = low levels of neutrophilic leukocytes. |
-EMIA | condition of blood | anaemia = abnormally low levels of red blood cells. |
L1 - ALL: small lymphoid cells, regular nuclei
L2 - ALL: large lymphoid cells, irregualr nuclei
L3 - ALL: large homogeneous cells with prominent nucleolus
M1 - Myeloblastic leukemia without maturation
M2 - Myeloblastic leukemia with maturation
M3 - Promyelocytic leukemia
M4 - Myelomonocytic leukemia
M5 - Monocytic leukemia
M6 - Erythroleukemia
M7 - Megakaryoblastic leukemia
M0 - AML with minimal differentiation
Related Abbreviations and Acronyms:
AA | Anaplastic Anaemia |
ALL | Acute lymphoblastic leukaemia |
AML | Acute Myeloid leukaemia |
ANC | Absolute neutrophil count |
ANLL | Acute non-lymphatic leukaemia |
ASH | American Society for Hematology |
B-ALL | B-cell Acute Lymphoblastic Leukaemia |
BP | Blood pressure |
CALGB | Cancer and Leukemia Group B (USA) |
cALL | Common ALL |
CGL | Chronic Granulocytic Leukaemia |
CHF | Congestive heart failure |
CLL | Chronic lymphocytic Leukaemia |
CML | Chronic myeloid leukaemia |
CMML | chronic myelomonocytic leukemia |
CPR | Cardio pulmonary resuscitation |
CVA | Cardiovascular Accident (stroke) |
CVC | Central venous catheters |
ECG | Electrocardiogram - heart scan |
FAB | French American and British classification scheme for leukaemia |
FBC | Full Blood Count |
G-CSF | Granulocyte colony stimulating factor promotes production of white blood cells |
GM-CSF | Granulocyte and macrophage colony stimulating factor |
Hb | Haemoglobin |
HCL | Hairy Cell Leukaemia |
HD | Hodgkin's Disease (lymphoma) |
HTLV | Human T-cell leukemia-lymphoma virus |
IV | Intravenous - into a vein |
LRF | Leukaemia Research Fund (UK) |
LVEF | Left Ventricular Fjection Fraction - a heart function test |
LVSF | Left Ventricular Shortening Fraction - a heart function test |
MM | Multiple Myeloma |
RBC | Red blood cell / red blood count |
WBC | White blood cell count |
WCC | White cell count |
component | meaning | example |
CHOLE- | bile / gall | cholecystectomy = removal of the gallbladder. |
CYSTO- | bladder / sac | cystitis = inflammation of the urinary bladder. |
GASTR- | stomach | gastritis = inflammation of the stomach. |
HEPATO- | liver | hepatitis = inflammation of the liver. |
NEPHR- | kidney | nephrotoxic = toxic to the kidney. |
PROCTO- | anus / rectum | proctalgia = pain in the rectum. |
REN- | kidney | renal failure |
-OSTOMY | create an opening | colostomy = surgical opening into the colon. |
-TOMY | cutting into | nephrectomy = removal of a kidney. |
Related Abbreviations and Acronyms:
CRC | Colorectal carcinoma |
CRF | Chronic renal failure |
EDTA | ethylendiaminetetraacetic acid - used in measuring kidney function |
EMUO | Early Morning Urine Osmolality (evaluating urine concentration) |
GFR | Gromerular filtration rate |
GI | Gastrointestinal |
HCC | Hepatocellular Carcinoma |
IVP | Intravenous Pyelogram - type of Xray after injection with iodine dye |
NKCA | National Kidney Cancer Association (USA) |
PUD | Peri-Urethral Diathermy (associated with superficial bladder cancer) |
SGOT | Serum glutamic oxalacetic transaminase - a liver function test |
SGPT | Serum glutamic pyruvic transaminase - a liver function test |
TCC | Transitional Cell Carcinoma (usually bladder cancer) |
U&Es | Urea and Electrolites |
UA | Urine analysis |
UTI | Urinary Tract Infection |
Radiation therapy given to children may lead to reduced growth in the bones and muscles in the affected area, for example when the patient reaches adulthood one limb might be slightly shorter than the other.
OncoLink manuscript:
Effects of Therapeutic Irradiation on Skeletal Growth in Children
Related Abbreviations and Acronyms:
DI | Diabetes Incipidus |
FMTC | Familial Medullary Thyroid Carcinoma |
HCG | Human Chorionic Gonadotrophin (hormone) |
I-131 | Radioactive Iodine |
MEN | Multiple Endocrine Neoplasia - (familial) a.k.a. FMEN |
Therefore by breaking down a complex word we can see that neuroblastoma literally means a tumour made up of immature nerve cells.
To take another type of tumour: osteogenic sarcoma
Thus we can see that this is a bone forming tumour.
All medical terms have a root word. They may also have a prefix, a suffix, or both a prefix and a suffix.
component | meaning | example |
BLAST- | germ, immature cell | blastoma = a cancer made of immature cells |
CARCIN- | cancer | carcinogenic = cancer causing |
CARDIO- | heart | cardiotoxicity = toxicity to the heart |
CYTO- | cell | cytotoxic = toxic to the cell |
DERMA- | skin | dermatitis = inflammation of the skin |
HISTIO- | tissue | histology = study of tissue |
HEPATI- | liver | hepatoblastoma = liver cancer |
MALIGN- | bad / harmful | malignant = growing, spreading |
NEPHRO- | kidney | nephrotoxic = harmful to the kidneys |
NEURO- | nerves | neurob1ast = an immature nerve cell |
ONCO- | mass / tumour | oncology = the study of cancer |
OSTEO- | bone / bony tissue | osteosarcoma = bone cancer |
PAED- | child | paediatric oncology = study of childhood cancer |
SARCO- | tissue | sarcoma = tumour of bone, muscle, or connective tissue |
TOXO- | poison | toxicology = study of poisons |
component | meaning | example |
-AEMIA | condition of blood | leukaemia = cancer of blood cells |
-ECTOMY | excision / removal | nephrectomy = excision of a kidney |
-ITIS | inflammation | hepatitis = inflammation of the liver |
-OLOGY | study / science of | cytology = the study of cells |
-OMA | tumour | retinoblastoma = tumour of the eye |
-PATHY | disease | neuropathy = disease of the nervous system |
-OSIS | disease /condition | necrosis = dying cells |
component | meaning | example |
AN-, A- | without / lack of | anaemia = lack of red blood cells |
AB- | away from | abnormal = away from the normal |
AD- | near / toward | adrenal gland = gland near to the kidney |
BI- | two / both | bilateral Wilm's = tumour in both kidneys |
DYS- | difficult / painful | dysfunction = not working properly |
ECTO- | outside | ectopic pregnancy = outside the uterine cavity |
ENDO- | inside | endoscope = an instrument to look inside the body cavities or organs |
EPI- | upon | epidermis = the outer layer of skin |
HYPER- | excessive / above | hyperglycaemia = excessive blood sugar levels |
HYPO- | beneath / below | hypodermic = injection below the skin |
INTER- | between | intercostal = between the ribs |
INTRA- | within / Inside | intravenous = into a vein |
PARA- | beside, about, near | parathyroid = beside the thyroid gland |
PERI- | around | pericardium = membrane around the heart |
PRE- | before | prenatal = before birth |
POST- | after | post surgical stage = stage after surgery |
SUB- | under / below | submucosa = tissue below mucus membrane |
SYN- | together with | syndrome = group of symptoms occurring together |
3DCRT | 3 Dimensional Conformal Radiotherapy |
5-FU | 5-Fluorouracil (anti cancer drug) |
6-MP | 6-Mercaptopurine (anti cancer drug) |
6-TG | 6-Thioguanine (anti cancer drug) |
AA | Anaplastic Anaemia |
AACR | American Association for Cancer Research |
ABC | Advanced Breast Cancer |
ABMT | Autologous bone marrow transplant |
ABPI | Association of the British Pharmaceutical Industry |
ABTA | American Brain Tumour Association |
ACDM | Association for Clinical Data Management |
ACRPI | Association of Clinical Research for the Pharmaceutical Industry |
ACS | American Cancer Society |
ADR | Adverse Drug Reaction |
AE | Adverse event |
AFP | Alphafetoprotein - eg. expressed by germ cell tumours and other cancers |
AIDS | Acquired immune deficiency syndrome |
AIOM | Italian Association for Medical Oncology |
AIRO | Associazione Italiana di Radioterapia Oncologica |
AJCC | American Joint Committee on Cancer |
ALAT | Alanine aminotransferase / alinine transaminase |
ALCL | Anaplastic Large-cell Lymphoma |
ALL | Acute lymphoblastic leukaemia |
ALT | Alanine Aminotransferase |
AMKL | acute megakaryocytic leukemia |
AML | Acute Myeloid leukaemia |
ANC | Absolute neutrophil count |
ANED | Alive no evidence of disease |
ANLL | Acute non-lymphatic leukaemia |
ARMS | Alveolar rhabdomyosarcoma |
ASCO | American Society of Clinical Oncology |
ASH | American Society for Hematology |
ASR | Age Standardised Rate (Incidence) |
ASTRO | American Society for Therapeutic Radiology and Oncology |
AUC | Area under the curve |
B-ALL | B-cell Acute Lymphoblastic Leukaemia |
BACR | British Association for Cancer Research |
BAER | Brainstem Auditory Evoked Responce |
BASO | British Association of Surgical Oncologists |
BCC | Basal Cell Carcinoma |
BID / BD | Twice a day (bis in die) |
BM | Bone Marrow |
BM | Blood Monitoring (eg for glucose) |
BMA | British Medical Association |
BMJ | British Medical Journal |
BMR | Basal Metabolic Rate |
BMT | Bone Marrow Transplant |
BNF | British National Formulary |
BNLI | British National Lymphoma Investigation |
BOA | British Oncology Association |
BODMA | British Oncology Data Managers Association (UK) |
BP | Blood pressure |
BRM | Biological Response Modifier |
BSA | Body Surface Area |
BSE | Breast Self Examination |
Bx | Biopsy |
C/O | Complaining of |
C/W | Continue With |
C1 - C7 | Cervical vertebrae (spine eg. C7 = seventh cervical vertebra) |
Ca | Cancer; carcinoma |
Ca | Calcium |
CALGB | Cancer and Leukemia Group B (USA) |
cALL | Common ALL |
CAT | Computerised axial tomography (scan) |
cc | Cubic centimeter |
CCF | Congestive Cardiac Failure |
CCG | Children's Cancer Group (USA) |
CCR | Continuous complete remission |
CCRG | Children's Cancer Research Group (Oxford, UK) |
CCS | Canadian Cancer Society |
CEA | Carcinoembryonic Antigen (tumour marker) |
CGH | Comparative Genomic Hybridisation - cytogenetics method |
CGL | Chronic Granulocytic Leukaemia |
cGy | Centi Gray (unit of radiation) |
CHF | Congestive heart failure |
CLL | Chronic lymphocytic Leukaemia |
cm | centimeter - 0.01 meters |
CML | Chronic myeloid leukaemia |
CMML | chronic myelomonocytic leukemia |
CMV | Cytomegalo virus |
CNS | Central nervous system - the brain and spine |
COS | Canadian Oncology Society |
CPM | Cyclophosphamide (anti cancer drug) |
CPR | Cardio pulmonary resuscitation |
CR | Complete remission / complete response |
CRA | Clinical Research Associate |
CRC | Cancer Research Campaign (UK) |
CRC | Colorectal carcinoma |
CRF | Case Report Forms |
CRF | Chronic renal failure |
CRO | Contract Research Organisation |
CSF | Cerebro spinal fluid |
CSF | Colony-stimulating Factor |
CSM | Committee on Safety of Medicines (UK) |
CT | Computerised axial tumography (scan) |
CT | Chemotherapy |
CTC | Common Toxicity Criteria |
CTCL | Cutaneous T-Cell Lymphoma |
CTO | Clinical Trials Office |
CTX | Clinical Trials Exemption |
CVA | Cardiovascular Accident (stroke) |
CVC | Central venous catheters |
CVP | Central Venous Pressure |
CXR | Chest X-Ray |
D/C | Discharge |
D/H | Drug History |
D/W | Discussed With |
DCIS | Ductal Carcinoma In Situ - type of breast cancer |
DDAVP | Desmopressin test for urine osmolality |
DDx | Differential diagnosis |
DFI | Disease Free Interval |
DFS | Disease Free Survival - time without disease prior to relapse or last follow-up |
DI | Diabetes Incipidus |
dl | deciletre - 0.01 litres |
DLBCL | Diffuse Large B-cell Lymphoma |
DLCL | Diffuse large-cell lymphoma |
DLS | Date last seen |
DLT | Dose limiting toxicity - determined by phase 1 studies |
DMC | Data Monitoring Commitee |
DNA | Deoxyribonucleic acid |
DNA | Did Not Attend (clinic) |
DNR | Do Not Resusitate |
DOA | Dead on Arival |
Dx | Diagnosis |
EACR | European Association for Cancer Research |
EANO | European Association for NeuroOncology |
EBM | Evidence-Based Medicine |
EBMT | European Group for Blood and Marrow Transplantation |
EBV | Epstein-Barr Virus |
ECG | Electrocardiogram - heart scan |
ECOG | Eastern Cooperative Group (USA) |
EDTA | ethylendiaminetetraacetic acid - used in measuring kidney function |
EEG | Electroencephalogram - brain scan |
EFS | Event Free Survival - time from diagnosis to defined events (eg relapse or deat |
EICESS | European Intergroup Ewing's Sarcoma Study |
EJC | European Journal of Cancer |
EMUO | Early Morning Urine Osmolality (evaluating urine concentration) |
ENSG | European Neuroblastoma Study Group |
ENT | Ear nose throat |
EOI | European Osteosarcoma Intergroup |
EORTC | European Organisation for Research and Treatment of Cancer |
ESO | European School of Oncology |
ESR | Erythrocyte Sedimentation rate |
ESTRO | European Society for Therapeutic Radiation and Oncology |
ETS | Environmental Tobacco Smoke |
F/H | Family history |
FAB | French American and British classification scheme for leukaemia |
FBC | Full Blood Count |
FDA | Food and Drug Administration (USA) |
FECS | Federation of European Cancer Societies |
FEV | Forced expectorant volume (a lung test) |
FFA | For Further Appointment |
FIGO | Federation Internat. Gyn. Obst. (FIGO Gynaecological staging system) |
FISH | Flourescence in situ Hybridisation |
FMTC | Familial Medullary Thyroid Carcinoma |
FNA | Fine Needle Aspiration - a type of biposy using a thin needle (or FNAB) |
FU | Follow up |
FVC | Forced Vital Capacity |
g | gram - unit of weight |
G-CSF | Granulocyte colony stimulating factor promotes production of white blood cells |
GA | General Anaesthetic |
GCP | Good Clinical Practice (guidelines) |
GCT | Germ Cell Tumour |
GCT | Giant Cell Tumour Context: bone tumours |
GFR | Gromerular filtration rate |
GI | Gastrointestinal |
GM-CSF | Granulocyte and macrophage colony stimulating factor |
GMC | General Medical Council (UK) |
GPOH | Gesellschaft fur Padiatrische Onkologie und Hamatologie (German Paed. Onc Group) |
GPR | Good Partial Remission |
GU | Genito-urinary |
GvHD | Graft versus Host Disease |
Gy | Grays (units of radiation) |
H&E | Hematoxylin and Eosin (stain) |
H/O | History of |
Hb | Haemoglobin |
HCC | Hepatocellular Carcinoma |
HCG | Human Chorionic Gonadotrophin (hormone) |
HCL | Hairy Cell Leukaemia |
HCO3 | Bicarbonate |
HD | Hodgkin's Disease (lymphoma) |
HD | High dose |
HDC | High Dose Chemotherapy |
HIV | Human Immunodeficiency Virus |
HL-A | Human Leukocyte Associated antigens (HL-A matching for BMT) |
HNPCC | Hereditary NonPolyposis Colorectal Cancer |
HPV | Human Papilloma Virus - implicated in some gynacological cancers |
HR | High risk |
HRT | Hormone replacement therapy |
HTLV | Human T-cell leukemia-lymphoma virus |
I-131 | Radioactive Iodine |
IACR | International Association of Cancer Registries |
IARC | International Agency for Research on Cancer |
IASLC | International Association for the Study of Lung Cancer |
ICARE | International Cancer Alliance for Research and Education (ICARE) |
ICCCPO | International Confederation of Childhood Cancer Parent Organisations |
ICCG | International Collaborative Cancer Group |
ICCPO | Icelandic Childhood Cancer Parent Organisation |
ICD | International Classification of Diseases (coding system) |
ICDO | International Classification of Diseases for Oncology (coding system) |
ICF | Intercellular fluid |
ICH | International Conference on Harmonization (GCP) |
ICRF | Imperial Cancer Research Fund (UK) |
ICU | Intensive Care Unit |
IESS | Intergroup Ewing's Sarcoma Study (USA) |
IL2 | Interleukin2 |
IM | Intramuscular - into a muscle |
IMF | International Myeloma Foundation |
IMRT | Intensity-Modulated Radiotherapy |
INFA | International Neurofibromatosis Association |
INSS | International Neuroblastoma Staging System |
IPSO | International Society of Pediatric Surgical Oncology |
ITU | Intensive Therapy Unit |
IU | International units |
IV | Intravenous - into a vein |
IVP | Intravenous Pyelogram - type of Xray after injection with iodine dye |
IWMF | International Waldenstrom's Maroglubulinemia Foundation |
JCO | Journal of Clinical Oncology |
K+ | Potassium |
kg | Kilogram - a thousand grams |
l | liter - unit of volume |
L1 - L5 | Lumbar vertebrae 1 - 5 (spine eg. L1 = 1st lumbar vertebra) |
LCH | Langerhans cell histiocytocis |
LCIS | Lobular Carcinoma In Situ - type of breast cancer |
LDH | Lactic dehydrogenase -high levels correlate with tumour volume in some cancers |
LMM | Lentigo Maligna Melanoma |
LMP | Low Malignant Potential (context: ovarian tumours) |
LN | Lymph Node |
LP | Lumbar puncture |
LREC | Local Research Ethics Committee (UK) |
LRF | Leukaemia Research Fund (UK) |
LRFA | Lymphoma Research Foundation of America |
LVEF | Left Ventricular Fjection Fraction - a heart function test |
LVSF | Left Ventricular Shortening Fraction - a heart function test |
Lx | Lumpectomy |
m | meter (unit of length) |
M/H | Medical history |
MAB - mAb | Monoclonal antibody |
MCA | Medicines Control Agency (UK) |
MDR | Multi drug resistant |
MDS | Myelo dysplastic syndrome |
MEN | Multiple Endocrine Neoplasia - (familial) a.k.a. FMEN |
mEq/l | milliequivalent per liter |
mets | Metastases (where the tumour has spread to secondary sites) |
Mg | Magnesium |
mg | milligram - 0.001 gram |
MI | Miocardial Infarction |
mIBG | Radioactive Iodine Metaidobenzoguanidine (mIBG scans or mIBG therapy). |
ml | millilitre 0.001 liter |
MM | Malignant Melanoma |
mM | millimole |
mm | millimeter - 0.001 meters |
MM | Multiple Myeloma |
mOsm | milliosmole |
MPNST | Malignant Peripheral Nerve Sheath Tumour |
MPO | Medical and Pediatric Oncology (journal) |
MRC | Medical Research Council (UK) |
MREC | Multi-centre Research Ethics Committee (UK) |
MRI | Magnetic resonance imaging (scan) |
MRT | Malignant Rhabdoid Tumour |
MSSU | Mid stream specimen urine |
MTD | Maximum tolerated dose - phase 1 studies |
MTX | Methotrexate (anti cancer drug) |
MUD | Matched Urelated Donor - for bone marrow transplant |
Mx | Mastectomy |
N/V | Nausea and vomiting |
Na+ | Sodium |
NAACCR | North American Association of Central Cancer Registries |
NABCO | National Alliance of Breast Cancer Organizations |
NAD | No Abnormality Detected |
NBCCS | Nevoid basal cell carcinoma syndrome |
NBM | Nil by mouth |
NCCF | National Childhood Cancer Foundation (USA) |
NCI | National Cancer Institue (USA) |
NCIC | National Cancer Institute of Canada |
NCRA | National Cancer Registrars Association (USA) |
NECCR | North of England Children's Cancer Research Unit |
NED | No evidence of disease |
ng | nanogram - 0.000000001 gram |
NHL | Non Hodgkin's Lymphoma |
NK | Natural Killer cells (large lymphocytes, part of the immune system) |
NK | Not known |
NKCA | National Kidney Cancer Association (USA) |
NM | Nodular Melanoma |
NMR | Nuclear magnetic resonance (scan) |
NMSC | Non Melanoma Skin Cancer |
NNFF | National Neurofibromatosis Foundation (USA) |
NORD | National Organization for Rare Disorders (USA) |
NOS | Not otherwise specified (see ICDO) |
NPC | Nasopharyngeal Carcinoma |
NRCT | National Registry of Childhood Tumours (UK) held by the CCRG at Oxford |
NRSTS | Non-Rhabdomyosarcoma Soft Tissue Sarcoma |
NSCLC | Non-small cell lung cancer |
NSE | Neuron-Specific Enolase - a neural marker |
NSR | Non significant result |
NSR | Normal Sinus Rhythem |
O/E | On Examination |
OECI | Organization of European Cancer Institutes |
ONB | Olfactory Neuroblastoma |
OS | Overall Survival |
OS | Osteogenic sarcoma (context bone tumours) |
PBSC | Peripheral Blood Stem Cell (see PBSCT) |
PBSCH | Peripheral Blood Stem Cell Harvest |
PBSCR | Peripheral Blood Stem Cell Rescue (transplant) |
PBSCT | Peripheral Blood Stem Cell Transplant |
PD | Progressive disease |
PDQ | Physician's Data Query (CancerNet) |
PET | Positron Emmission Tomography- a scan after a small radioactive injection. |
PET | Pancreatic Endocrine Tumor |
PFS | Progression Free Survival |
pg | picogram - 0.000000000001 gram |
pH | hydrogen-ion concentration - acid / alkaline |
PH | Past History |
PLB | Primary Lymphoma of Bone |
PNET | Primitive neuroectodermal tumour Context: CNS tumours |
PNET | Peripheral neuroectodermal tumour Context: Bone tumours - see Ewing's tu |
PNS | Peripheral nervous system - nervous system outside the brain and spine. |
POG | Pediatric Oncology Group (USA) |
PONF | Paediatric Oncology Nurses Forum (UK) |
PR | Partial Responce / Partial Remission |
PR | per rectum |
prn | as required |
prn | whenever necessary (pro re nata) |
PSA | prostate-specific antigen - PSA test used in screening for prostate cancer |
PUD | Peri-Urethral Diathermy (associated with superficial bladder cancer) |
QALY | Quality-Adjusted Life Year |
qid | Four times a day (quater in die) |
QoL | Quality of Life |
RBC | Red blood cell / red blood count |
RCT | Randomised Controlled Trial |
RFS | Relapse free survival - Time from diagnosis to relapse or death. |
RIGS | Radioimmunoguided surgery |
RMS | Rhabdomyosarcoma |
RNA | ribonucleic acid |
RT | Radiotherapy |
RTPCR | Reverse transcriptase polymerase chain reaction |
Rx | Treatment |
SA | Surface area (see BSA) |
SAE | Serious Adverse Event |
SC | Subcutaneous |
SCC | Squamous Cell Carcinoma |
SCLC | Small cell lung cancer |
SCTN | Scottish Cancer Therapy Network |
SD | Stable Disease |
SDV | Source Data Verification |
SEER | Surveillance, Epidemiology, and End Results (USA) |
SFOP | French Paediatric Oncology Scociety |
SGDM | Study Group on Data Management (EORTC) |
SGO | Society of Gynecologic Oncologists |
SGOT | Serum glutamic oxalacetic transaminase - a liver function test |
SGPT | Serum glutamic pyruvic transaminase - a liver function test |
SH | Social history |
SHO | Senior House Officer |
SIADH | Syndrome of Inappropriate Antidiuretic Hormone |
SIOP | International Society of Paediatric Oncology |
SNLG | Scottish and Newcastle Lymphoma Group |
SNP | Single Nucleotide Polymorphism |
SOB | Short of breath |
SPOHNC | Support for People with Oral and Head and Neck Cancer |
SSM | Superficial Spreading Melanoma |
SWOG | Southwest Oncology Group (USA) |
T1 - T12 | Thoracic vertebrae 1-12 (spine eg. T10 = tenth thoracic vertibra) |
TBI | Total body irradiation |
TCC | Transitional Cell Carcinoma (usually bladder cancer) |
TCP | Thrombocytopenia |
tds / tid | Three times a day (ter in die) |
TNF | Tumour Necrosis Factor |
TNM | Staging system - primary tumour |
TPN | total parenteral nutrition |
TRK | Transketolase |
U&Es | Urea and Electrolites |
UA | Urine analysis |
ug | microgram - 0.000001 gram |
UICC | Union Internationale Contre le Cancer - International Union Against Cancer |
UKACR | UK Association of Cancer Registeries |
UKCCCR | UK Coordinating Committee for Cancer Research |
UKCCRG | UK Children's Cancer Research Group (Oxford) |
UKCCSG | UK Children's Cancer Study Group (UK) |
ULN | Upper Limits of Normal |
URTI | Upper respiratory tract infection |
US | Ultasound (scan) |
UTI | Urinary Tract Infection |
UVR | Ultra Violet Radiation |
VEF | Ventricular ejection fraction (tests lung function) |
VM-26 | Teniposide (anti cancer drug) |
VMA | Vanillylmandelic Acid |
VP-16 | Etoposide (anti cancer drug) |
WBC | White blood cell count |
WCC | White cell count |
WHO | World Health Organisation |
XRT | Radiotherapy (external) |
YST | Yolk sac tumour - another name for germ cell tumour |